CDC weighs risk of BA.2.86 COVID-19 lineage

CDC weighs risk of BA.2.86 COVID-19 lineage

The US Centers for Disease Control and Prevention (CDC) issued its initial risk assessment of the BA.2.86 SARS-CoV-2 lineage, which says tests and treatments will likely be effective and that updated vaccines will still be able to reduce severe disease and...
COVID-19 vax lowers severity, mortality post infection

COVID-19 vax lowers severity, mortality post infection

In one of the largest studies of its kind, researchers provide answers to whether COVID-19 vaccinations reduce sickness and mortality following infection with SARS-CoV-2. The study published in The Lancet Microbe found among individuals recently infected with...
Study finds new way to stop excess COVID inflammation

Study finds new way to stop excess COVID inflammation

By Maria Fernanda Ziegler  |  Agência FAPESP – Researchers at the University of São Paulo (USP) in Brazil have identified a new class of molecules capable of stopping the excessive inflammation typical of the severe form of COVID-19 without impairing the immune...